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ABSTRACT: A convergent and stereoselective approach for the
synthesis of marine natural product (MNP) phormidolide D
(PM D) is proposed. Two main disconnections divided PM D in
three molecular fragments: the macrocyclic core 4, the stapling
iodoalkene 9 corresponding to the central part of PMs, and the
east fragment 5 that includes the unusual bromo-methoxy-diene
moiety and a tetradecanoic acid ended with a (E)-dichloro-ene
functionality. Procedures for the preparation of compounds 5, 9,
and the never-reported fatty acids 7 and 8, present in PMs C and
D, respectively, have been afforded with good yields and high
degree of stereoselectivity. The absolute configuration of all of
the generated stereocenters has been established. The reaction to
link iodoalkene 9 and formylmacrolactone 4, using the Nozaki−
Hiyama−Takai−Kishi coupling, gave an advanced synthetic
intermediate with total stereocontrol. Finally, a deeper study of protecting groups and reaction conditions for the last step of
the synthesis is needed. All the information gathered in this publication will be of great value to continue performing synthetic
studies for the preparation of these NPs. The versatility and the presence of a common polyol chain in oscillariolide and PMs A−
C would allow applying the same retrosynthesis for the synthesis of the mentioned MNP.
■ INTRODUCTION
Polyketides, and more specifically macrolides, represent a
family of marine natural products (MNPs) of great interest
from a biological-therapeutical point of view,1 but at the same
time, they show high complex molecular architectures that
make their syntheses a real challenge. Phormidolides C and D
(Scheme 1, PMs C and D, 1−2) are marine polyketides isolated
by the biotech company PharmaMar that showed cytotoxic
activity in three tumor cell lines with an unknown mechanism
of action.2 From a structural point of view, PMs C and D
present 13 stereocenters and 5 di- and trisubstituted double
bonds distributed in the following moieties: a tetrahydrofuran
(THF)-containing macrolide (C1−C14), a polyhydroxylated
chain (C15−C31) terminated with a unusual bromo-metoxy-
diene moiety, and two different tetradecanoic fatty acids (C39−
C52) containing a terminal (E)-dichloro-ene or (E)-bomo-
chloro-ene functionalities linked to the C27 hydroxylic
position.a So far, and to the best of our knowledge, no total
synthesis of PMs C and D or the related PM A3 and
oscillariolide4 has been described.
The structural and stereochemical elucidation of PMs C and
D were carried out through mono- and bidimensional advanced
NMR techniques (1H, 13C, 1D-TOCSY, gCOSY, gHSQC, and
gHMBC) and high-resolution mass spectroscopy (HRMS).b
The relative configuration of stereocenters present in the
macrocyclic core was determined using rotational nuclear
Overhauser effect spectroscopy combined with the J-based
configuration analysis and nuclear Overhauser effect experi-
ments. The two only stereocenters, with unclear configuration
after the NMR analysis, were C3 and C14 positions. To solve
this issue, our group reported the chemical syntheses of three
different diastereomeric protected macrocyclic cores (C1−C15
fragment). NMR comparison of the synthetic and natural
products suggested to us that the 3R,14R configuration was the
most plausible one.2 A second-generation synthesis of the C1−
C15 moiety with the mentioned stereochemistry, after the
removal of the protecting groups, enabled a second NMR
comparison with the NP which showed high similarity, hence
confirming our 3R and 14R stereochemical hypothesis.5
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Stereochemistry of the C15−C31 fragment, common to
oscillariolide4 and PM A,3 was determined by the chemical shift
and the coupling constant in comparison with PM A, whose
absolute configuration was previously determined by Gerwick
and co-workers. Recently, our group described the synthesis of
the C19−C31 polyhydroxylated chain,6 including the tricky
bromo-methoxy-diene motif.7 This allowed a new NMR
chemical shift comparison between the synthetic and NPs
showing high degree of similarity, thereby confirming the
absolute configuration of the polyol chain by chemical
synthesis.
Our initial proposed retrosynthesis (Scheme 1, a) explained
during the enantioselective synthesis of the polyhydroxylated
chain was based on a single disconnection through the C15−
C16 bond.6 Both fragments 3 and 4 would be linked in the last
step of the synthesis through a Nozaki−Hiyama−Takai−Kishi8
(NHTK) coupling reaction. However, this approach posed
some clear disadvantages. First, a high number of linear
synthetic steps for the preparation of 3 would be required, and
the introduction of the C16 iodoalkene functionality would not
be trivial. Second, a possible lack of chemoselectivity in the
formation of C15−C16 bond using NHTK conditions could
have occurred because of the presence of other reactive
positions in 3 such as C31 or C52. For these reasons, a new
retrosynthetic analysis that overcame all the above-mentioned
problems was necessary.
The new synthetic approach (Scheme 1, b) envisions a
disconnection through the C22−C23 bond to create it at the
end of the route through a previously optimized6 Mukaiyama
aldol addition from aldehyde 5 (C23−C31) and methyl ketone
6 (C1−C22). Fatty acids 7 and 8 present in different PMs
would be synthesized separately and esterified at the C27
position during the synthetic route toward 5. Then, fragment 6
would be planned to be prepared by means of the NHTK8
coupling of enantiopure iodoalkene 9 (C16−C22) and the
previously reported C1−C15 fragment aldehyde 4.5 A reliable
preparation of central fragment 9 is crucial because of its useful
bivalent nature (methyl ketone and iodoalkene) that allows its
use as a “stapling” compound between macrocycle 4 and
aldehyde 5.
Herein, we report the preparation of fatty acids 7 and 8,
present on both PMs C and D, and the synthesis of aldehyde 5
and iodoalkene 9. Furthermore, with fragments 5, 9, and 4 in
hand, the first synthetic approach for the synthesis of MNP PM
D (PM D) is discussed.
■ RESULTS AND DISCUSSION
Fatty Acids Preparation. Tetradecanoic acids containing
(E)-dihalogenated terminal double bonds were prepared by
direct dihalogenation of the corresponding terminal alkyne
using the methodology developed by Negoro and Ikeda.9 The
use of these halogenation conditions had important advantages
such as good yields, easy experimental setup, mild conditions,
stereospecificity toward the (E) double bond, and regioselec-
tivity for the desired isomer in the case of bromochlorination.
The synthetic route was initially started using commercially
available 11-bromo-1-dodecanol 10 through the protection of
the hydroxyl prior to the alkyne introduction and through triple
bond halogenation. The tetrahydropyranyl (THP) protecting
group was chosen as the most convenient protecting group for
the whole synthetic route.c After the THP protection of 10 and
acetylide introduction, alkyne 11 was obtained in high yield.
This compound is common to both synthetic routes for the
preparation of fatty acids 7 and 8 (Scheme 2). The key reaction
of 11 with tetrabutylammonium dichlorobromide (TBADCB)
Scheme 1. (a) First Retrosynthetic Analysis for the
Preparation of PMs C and D and (b) Second-Generation
Retrosynthesis Described in This Publication
Scheme 2. Preparation of the Fatty Acids Present in PMs C
and Da
aReagents and conditions: (a) PPTS, CH2Cl2, 3,4-dihydro-2H-pyran,
rt, 95%; (b) lithium acetylide−diethylamine complex, DMSO, rt, 99%;
(c) TBADCB, CH2Cl2, rt; (d) tetrabutylammonium trichloride,
CH2Cl2, rt; (e) p-TsOH, MeOH, rt; (f) DMP, CH2Cl2, rt; (g)
NaClO2, NaH2PO4, 2-methyl-2-butene,
tBuOH/H2O, rt; and (h)
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in CH2Cl2 at room temperature (rt) produced terminal alkene
12 as a single (E) double-bond isomer. (E) Stereochemistry
was obtained due to the reaction mechanism.9 However,
compound 12 was obtained as an 89:11 mixture of inseparable
regioisomers.d The THP removal followed by a double Dess−
Martin and Pinnick oxidation rendered fatty acid 7 found in
PM C. Finally, 7 was protected as a methyl ester and purified to
obtain 14 in good yield with a single final purification from 11.
It is important to mention that this final protection was
performed to facilitate the purification process and to enhance
the stability of the compound for long-term storage.
A similar synthetic route was followed for the preparation of
8, using tetrabutylammonium trichloride for the halogenation
of 11. This salt was prepared by the reaction of
tetrabutylammonium chloride with in situ generated chlorine.10
Protected alkene 13 was obtained as a single stereoisomer and
then, a deprotection−oxidation sequence similar to that used
for 7 delivered fatty acid 8. Finally, methyl ester protection and
purification produced ester 15. These two simple synthetic
routes allowed an easy, efficient, and scalable preparation of the
fatty acids present in PMs C and D.
Preparation of Fragment C23−C31 (5). With both fatty
acids in hand, the challenging preparation of aldehyde 5, the
east end of the molecule, was investigated. The route was
started from the previously reported alcohol 16 (Scheme 3).6 t-
Butyldimethylsilyl (TBS)-hydroxyl protection, DIBAL-H re-
gioselective ketal reduction,11 and Swern oxidation afforded
aldehyde 17 with good synthetic yields at the gram scale. Then,
the Mukaiyama aldol addition of (E)-((4-bromo-3-methox-
ybuta-1,3-dien-2-yl)oxy)trimethylsilane6 produced ketol 18 as
an inseparable mixture of diastereomers (82:18) enriched in the
undesired C27-(S) isomer.e Then, as it happened in our
previous work,6 a three-step procedure was necessary to
introduce the methylidene moiety including triethylsilane
(TES) protection of 18, olefination using the Tebbe reagent
and TES pyridinium p-toluenesulfonate (PPTS)-mediated
removal to afford homoallylic alcohol 19 in good yield. At
this point, C27-diastereomers were separated by column
chromatography and the absolute configuration of the major
isomer was confirmed using Mosher’s derivatization.12f
Mitsunobu hydroxyl inversion13 of 19, followed by basic
hydrolysis of the generated nitrobenzoate, cleanly delivered the
C27-(S) isomer compound 20. Then, alcohol 20 was esterified
with (E)-13,14-dichlorotetradec-13-enoic acid (8) to obtain the
protected C23−C31 fragment of PM D, ester 21. tert-
Butyldimethylsilyl (TBS) removal at position C23 and Dess−
Martin oxidation gave us access to aldehyde 5 in 12 steps with
useful yields from alcohol 16.
Preparation of Fragment C16−C22 (9). The synthesis of
the central bifunctionalized C16−C22 fragment 9 (Scheme 4)
began with the aldol addition of silylenolether 2214 to aldehyde
2315 to obtain ketol 24 as a C19 epimeric mixture. Several
reported enantioselective strategies using N-Ts-L-valine or a
tryptophan-derived oxazaborolidine as chiral inductors for this
addition were tested unsuccessfully.16,17 The racemic mixture
24 was reacted with the chiral (R)-methoxyphenylacetic acid
(MPA) to obtain the corresponding diastereomeric esters that
were easily separated via column chromatography to isolate the
desired C19-R epimer 25-R,R and its diastereomer 25-S,R.
Taking advantage of the fact that 25-S,R is the enantiomer of
25-R,S, and therefore spectroscopically identical; it was possible
to identify 25-R,R without additional derivatizations using
Mosher’s model.18f
Ester basic hydrolysis at this point was nonviable probably
because of methyl ketone known basic media instability;
Scheme 3. Preparation of Compound 5, Fragment C23−C31a
aReagents and conditions: (a) TBSCl, imidazole, CH2Cl2, 86%; (b) DIBAL, CH2Cl2, −20 to 0 °C, 90%; (c) DMSO, (COCl)2, Et3N, DCM, −78 °C,
80%; (d) (E)-((4-bromo-3-methoxybuta-1,3-dien-2-yl)oxy)trimethylsilane, BF3·Et2O, CH2Cl2, −78 °C, 47%; (e) TESCl, imidazole, CH2Cl2,
86%; (f) Tebbe reagent, pyridine, THF, 50 °C, 81%; (g) PPTS, MeOH, 88%; (h) diastereomer column chromatography separation; (i) PPh3, p-
nitrobenzoic acid, DIAD, THF; (j) K2CO3, MeOH, 59% for two steps; (k) 8, EDC·HCl, Et3N, DMAP, 61%; (l) TBAF, THF, 77%; and (m) DMP,
NaHCO3, CH2Cl2, 93%.
Scheme 4. Preparation of Compound 9, Fragment C16−
C22a
aReagents and conditions: (a) BF3·Et2O, CH2Cl2, 63%; (b) (R)-MPA,
EDC·HCl, DMAP, THF; (c) column chromatography to isolate C19
diastereomers 25-R,R, 41% and 25-S,R, 42%; (d) TMSOTf, 1,2-
bis(trimethylsiloxy)ethane, −78 °C to rt, 97%, (e) LiOH·H2O,
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therefore, C21 position had to be protected. Mild protecting
conditions20 to install the ketone 1,3-dioxolane protecting
group were used and subsequent LiOH-mediated ester
saponification rendered alcohol 26 in high yield for this two-
step transformation. Finally, alcohol protection using TBSOTf
and ketal removal to recover the methyl ketone delivered the
desired iodoalkene 9 as a single (R) enantiomer, as needed.
Endgame of the Synthesis. Having synthesized fragments
5, 9, and 4,5 the pieces of the synthetic puzzle should be put
together. First of all, the union of aldehyde 4 and iodoalkene 9
using the CrCl2−NiCl2-mediated NHTK coupling (Scheme 5,
a) was attempted.8,21 This methodology allowed the selective
formation of the C15−C16 bond in the presence of methyl
ketone because of the well-known chemoselectivity of NHTK
coupling toward aldehydes, thereby demonstrating the useful
orthogonal reactivity of compound 9. Unfortunately, the
reaction between 9 and 4 gave stereoselectively compound 6
possessing the configuration R-C15 with only 18% yield.8
Because of the low amount of compound 6 available, it was
decided to use the variable temperature (VT) Mosher
determination that allows assigning the absolute configuration
of a secondary alcohol performing a single derivatization.19
First, alcohol 6 was converted into its corresponding (R)-
methoxyphenylacetic ester 27. Then, 1H NMR of compound
27 in CD2Cl2 was recorded at 25 and −60 °C, and the C15-(R)
configuration was confirmed by calculating the increment in
chemical shift (Scheme 5, below).g
When the synthetic route was planned, the formation of the
C22−C23 bond was envisioned as its last step based on our
previous outstanding results on the formation of this bond
while working in the synthesis of the polyhydroxylated chain.
As depicted in Scheme 6a, the Mukaiyama addition of
silylenolether 2922 to aldehyde 28 gave not only almost
quantitative yield but also total stereoselectivity toward the
desired C23-(R) diastereomer 30.6 Bearing this precedent in
mind, methyl ketone and the hydroxyl present in compound 6
were simultaneously transformed into the corresponding
silylenolether and protected hydroxyl in quantitative yield to
render the nucleophile for the final Mukaiyama addition,
compound 31 (Scheme 6, b). However, when the Mukaiyama
Scheme 5. (a) NHTK Coupling To Obtain Alcohol 6, the C1−C21 Fragment and (b) Determination of C15 Absolute
configuration Using VT Mosher Methodology19a
aReagents and conditions: (a) CrCl2, NiCl2, DMF, 48 h, 18% and (b) (R)-MPA, EDC·HCl, DMAP, THF, 48 h.
Scheme 6. (a) Precedent Work in the Formation of the
C22−C23 Bond and (b) Endgame of the Total Synthesisa
aRegents and conditions: (a) BF3·Et2O, −78 °C, CH2Cl2 (5% Et2O),
2 h, 98%, dr = 98:2; (b) TMSOTf, Et3N, DMAP, CH2Cl2, rt, 4 h,
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addition of silylenolether 31 to aldehyde 5 (using the same
conditions applied for the preparation of 30) was performed,6
no conversion toward the product took place, recovering both
starting materials after column purification. Modification of the
reaction conditions by increasing the equivalents of BF3·Et2O
and the temperature to 0 °C resulted in no reaction either.
After these negative results, it was concluded that the formation
of the C22−C23 bond using the Mukaiyama methodology with
the coupling partners 5 and 31 was not possible in this case.
The reason for this lack of reactivity is unknown, but by
comparison with our reported precedents, it can be
hypothesized that steric congestion around carbons C22 and
C23 hinders reagents approximation. The presence of a
tetradecanoic ester (C27) and p-methoxybenzyl (PMB)
(C25) in aldehyde 5 reduces somehow the necessary carbonyl
activation by BF3·Et2O. In addition, a secondary TBSO-
protected hydroxyl (C19) in the large functionalized
compound 31 could suppress its reactivity as a nucleophile.
■ CONCLUSIONS
Highly convergent strategies are the process of choice for the
total synthesis of large NPs such as PM D. The synthetic
approach reported herein is composed of a total of 73 reactions,
but the longest synthetic sequence to achieve PM D is only 20
steps long (the preparation of 5 from the commercially
available starting material plus Mukaiyama addition and C21
reduction). The use of highly convergent strategies normally
relies on final complex reactions because large molecular
entities have to be efficient and stereoselectively linked.
In summary, this publication reports a highly convergent
approach toward the NP PM D. A robust and scalable synthesis
of fatty acids 7 and 8, present in PMs C and D, using a
stereoselective and regioselective halogenation of acetylene to
obtain (E)-dihalogenated terminal double bonds with high
yield under mild conditions is described. Stereoselective
efficient strategies for the preparation of 5 (C23−C31
fragment) and 9 (C16−C22 fragment) are fully described
setting up the conditions to achieve total synthesis. A notable
NHTK coupling of macrocyclic fragment 4 and iodoalkene 9
was performed in useful yield and with total substrate-
controlled diastereoselectivity.
Finally, the last C22−C23 bond formation using the
Mukaiyama methodology to link aldehyde 5 and silylenolether
31 did not work despite our previous encouraging results with
smaller molecules. These adverse results do not invalidate the
proposed retrosynthetic strategy that probably could give good
results using less hindered protecting groups. Therefore, a
revision of the protecting groups in positions C19 and C25
should be carried out before embarking on the synthesis of
these complex NPs. Consequently, all the information reported
in this publication will be of great value in the development of
the total synthesis of MNPs PMs B−D.
■ EXPERIMENTAL SECTION
General Procedures. THF and N,N-dimethylformamide
(DMF) were dried using a PureSolv solvent purification
system. All other solvents and reagents were used as purchased
without further purification, unless otherwise indicated. Flash
column chromatography was performed on silica gel (60A 35−
70 μm) as a stationary phase. Analytical thin-layer chromatog-
raphy (TLC) was performed on precoated silica gel 60 F254
plates (0.2 mm thick, 20 × 20 cm) and visualized under UV
light (254 and 360 nm), with anisaldehyde in concd H2SO4 or
with phosphomolybdic acid in ethanol. Chemical shifts are
reported in parts per million (ppm) referenced to the
appropriate residual solvent peaks (CDCl3), and coupling
constants are reported in hertz. Multiplicity of the carbons was
assigned with gHSQC experiments. Standard abbreviations for
off-resonance decoupling were employed: s = singlet, d =
doublet, t = triplet, q = quadruplet, bs = broad singlet, bd =
broad doublet, and m = multiplet. The same abbreviations were
also used for the multiplicity of signals in 1H NMR. HRMS was
performed in an Agilent LC/MSD-TOF 2006 system using the
electrospray ionization mass spectrometry (ESI-MS) technique.
2-((12-Bromododecyl)oxy)tetrahydro-2H-pyran. PPTS
(282 mg, 1.3 mmol) was added to a stirred solution of
commercial 12-bromododecan-1-ol (10) (2.00 g, 7.5 mmol) in
CH2Cl2 (50 mL), the reaction mixture was stirred for 5 min,
and 3,4-dihydro-2H-pyran (0.95 g, 11.3 mmol) was added. The
reaction mixture was allowed to stir at rt overnight under N2.
Then, it was quenched with a saturated solution of NaHCO3,
and the organic layer was extracted three times with Et2O. The
organic extract was washed with brine, dried over MgSO4, and
filtered. The filtrate was evaporated under reduced pressure.
The crude obtained (2.75 g) was purified by silica gel column
chromatography with hexane/EtOAc (95:5 to 90:10) to obtain
the title compound (2.51 g, 85%). 1H NMR (400 MHz,
CDCl3): δ 1.24−1.34 (m, 14H), 1.39−1.44 (m, 2H), 1.51−1.61
(m, 6H), 1.66−1.76 (m, 1H), 1.78−1.90 (m, 3H), 3.32−3.42
(m, 3H), 3.46−3.53 (m, 1H), 3.73 (dt, J = 9.6, 6.9 Hz, 1H),
3.82−3.90 (m, 1H), 4.55−4.60 (m, 1H). 13C NMR (100.6
MHz, CDCl3): δ 19.7 (t), 25.5 (t), 26.2 (t), 28.2 (t), 28.7 (t),
29.4 (t), 29.4 (t), 29.5 (t), 29.5 (t), 29.5 (t), 29.7 (t), 30.8 (t),
32.8 (t), 34.0 (t), 62.3 (t), 67.7 (t), 98.8 (d).
2-(Tetradec-13-yn-1-yloxy)tetrahydro-2H-pyran (11). The
lithium acetylide−ethylenediamine complex (1.37 g, 13.35
mmol) was stirred in dimethyl sulfoxide (DMSO, 10 mL) at
15−20 °C for 1 h. Then, a solution of the above-mentioned
bromide (2.51 g, 6.36 mmol) in DMSO (10 mL) was added at
rt for 2 h and under N2. The resulting mixture was stirred for 12
h. Then, it was quenched with water (10 mL), and the organic
layer was extracted three times with hexane. The organic extract
was washed several times with brine, dried over MgSO4, and
filtered. The filtrate was evaporated under reduced pressure.
The crude obtained (2.10 g) was purified by silica gel column
chromatography with hexane/EtOAc (99:1 to 97:3) to obtain
11 (1.47 g, 79%). 1H NMR (400 MHz, CDCl3): δ 1.22−1.39
(m, 15H), 1.47−1.61 (m, 9H), 1.64−1.74 (m, 1H), 1.76−1.86
(m, 1H), 1.92 (t, J = 2.7 Hz, 1H), 2.17 (td, J = 7.1, 2.7 Hz, 2H),
3.37 (dt, J = 9.5, 6.9 Hz, 1H), 3.45−3.52 (m, 1H), 3.72 (dt, J =
9.5, 6.9 Hz, 1H), 3.86 (ddd, J = 11.1, 6.9, 3.4 Hz, 1H), 4.53−
4.58 (m, 1H). 13C NMR (100.6 MHz, CDCl3): δ 18.4 (t), 19.7
(t), 25.5 (t), 26.2 (t), 28.5 (t), 28.7 (t), 29.1 (t), 29.5 (t), 29.5
(t), 29.7 (t), 30.8 (t), 62.3 (t), 67.7 (t), 68.0 (d), 84.8 (s), 98.8
(d).
(E)-2-((14-Bromo-13-chlorotridec-13-en-1-yl)oxy)-
tetrahydro-2H-pyran (12). TBADCB (4.16 g, 10.6 mmol) was
added to a solution of alkyne 11 (880 mg, 2.98 mmol) in
anhydrous CH2Cl2 (20 mL) at rt and under N2. The reaction
mixture was stirred for 2.5 h. Then, it was quenched with water
(10 mL), and the organic layer was extracted three times with
CH2Cl2. The organic extract was washed with brine, dried over
MgSO4, and filtered. The filtrate was evaporated under reduced
pressure to obtain 3.62 g of crude 12 as an 89:11 mixture of
regioisomers which was used in the next step without further
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purification. 1H NMR (400 MHz, CDCl3): δ 1.23−1.30 (m,
12H), 1.44−1.55 (m, 8H), 1.61−1.71 (m, 6H), 2.14 (td, J =
7.1, 2.7 Hz, 1H), 2.44−2.52 (m, 1H), 3.43−3.49 (m, 1H), 3.61
(t, J = 6.7 Hz, 1H), 3.66−3.71 (m, 1H), 3.79−3.87 (m, 1H),
4.52−4.56 (m, 1H), 6.18 (s, 1H).
(E)-14-Bromo-13-chlorotetradec-13-en-1-ol (S1). p-TsOH
(103 mg, 0.60 mmol) was added to a solution of alkene 12
(1.21 g, 2.97 mmol) in MeOH (20 mL), and the mixture was
stirred for 3 h at rt. Then, it was quenched with a saturated
solution of NaHCO3 (10 mL), and the organic layer was
extracted three times with Et2O. The organic layer was washed
with a saturated solution of NaHCO3 several times, dried over
MgSO4, and filtered. The filtrate was evaporated under reduced
pressure. The crude of S1 (1.22 g) was used in the next step
without further purification. 1H NMR (400 MHz, CDCl3): δ
1.30 (m, 14H), 1.56 (d, J = 7.4 Hz, 6H), 2.36−2.44 (m, 1H),
2.48−2.55 (m, 1H), 3.64 (t, J = 6.6 Hz, 2H), 6.22 (s, 1H). 13C
NMR (101 MHz, CDCl3): δ 25.7 (t), 26.3 (t), 28.5 (t), 29.3
(t), 29.4 (t), 29.5 (t), 29.5 (t), 29.6 (t), 29.6 (t), 32.8 (t), 35.1
(t), 63.1 (t), 101.0 (d), 136.9 (s).
(E)-14-Bromo-13-chlorotetradec-13-enal (S2). DMP (1.18
g, 2.70 mmol) was added to a solution of S1 (703 mg, 2.15
mmol) in dry CH2Cl2 (20 mL) at rt and under N2. The
reaction mixture was stirred for 3 h. Then, it was quenched with
a saturated solution of NaHCO3, and the saturated solution of
NaS2O3 and the mixture were left stirring for 20 min. The
aqueous layer was extracted three times with EtOAc, dried over
MgSO4, and filtered. The filtrate was evaporated under reduced
pressure. The crude of S2 (751 mg) was used in the next step
without further purification. 1H NMR (400 MHz, CDCl3): δ
1.30 (m, 14H), 1.57−1.66 (m, 4H), 2.40−2.45 (m, 2H), 2.53
(t, J = 7.4 Hz, 2H), 6.22 (s, 1H), 9.77 (s, 1H). 13C NMR (101
MHz, CDCl3): δ 22.1 (t), 26.3 (t), 28.5 (t), 29.2 (t), 29.3 (t),
29.3 (t), 29.4 (t), 29.4 (t), 29.5 (t), 35.1 (t), 43.9 (t), 101.1 (d),
136.9 (s), 202.9 (s).
(E)-14-Bromo-13-chlorotetradec-13-enoic Acid (7).
NaClO2 (832 mg, 9.2 mmol) was added to a solution of
aldehyde S2 (750 mg, 2.3 mmol) in tBuOH/H2O (10 mL/2
mL), in the presence of NaH2PO4 (1.4 g, 11.5 mmol) and 2-
methyl-butene (806 mg, 11.5 mmol), at rt. The reaction
mixture was stirred for 2 h and 30 min. Then, it was quenched
with water and Na2S2O3. The organic phase was extracted three
times with EtOAc and washed with brine. The organic extract
was dried over MgSO4 and filtered, and the solvent was
removed under reduced pressure. The crude 7 (794 mg) was
used in the next step without further purification. 1H NMR
(400 MHz, CDCl3): δ 1.29−1.36 (m, 14H), 1.53−1.68 (m,
4H), 2.35 (t, J = 7.5 Hz, 2H), 2.50−2.55 (t, J = 7.4 Hz, 2H),
6.22 (s, 1H). 13C NMR (101 MHz, CDCl3): δ 24.7 (t), 26.4
(t), 28.5 (t), 29.0 (t), 29.2 (t), 29.3 (t), 29.4 (t), 29.4 (t), 29.5
(t), 33.9 (t), 35.1 (t), 101.1 (d), 136.9 (s), 179.0 (s).
Methyl (E)-14-Bromo-13-chlorotetradec-13-enoate (14).
Trimethylsilyldiazomethane (TMSCHN2; 778 mg, 6.81
mmol) was added to a solution of 7 (774 mg, 2.27 mmol) in
CH2Cl2/MeOH (9:1) at 0 °C and under N2. The reaction
mixture was stirred for 3 h at 0−5 °C. The solvent was
evaporated under reduced pressure, and the residue was
purified in preparative RP-HPLC to obtain 14 (209 mg).
Global yield from 11 to 14 20%. 1H NMR (400 MHz, CDCl3):
δ 1.22−1.33 (m, 14H), 1.51−1.65 (m, 4H), 2.29 (t, J = 7.5 Hz,
2H), 2.46−2.55 (m, 2H), 3.66 (s, 3H), 6.21 (s, 1H). 13C NMR
(100.6 MHz, CDCl3): δ 24.9 (t), 26.3 (t), 28.5 (t), 29.1 (t),
29.2 (t), 29.3 (t), 29.4 (t), 29.4 (t), 29.5 (t), 34.1 (t), 35.1 (t),
51.4 (q), 101.0 (d), 136.9 (s), 174.3 (s). HRMS (ESI+) m/z:
calcd for C15H27BrClO2 (M + H), 353.0883; found, 353.0857.
(E)-2-((13,14-Dichlorotetradec-13-en-1-yl)oxy)tetrahydro-
2H-pyran (13). TBATC (3.96 g, 10.6 mmol) was added to a
solution of alkyne 11 (880 mg, 2.98 mmol) in dry CH2Cl2 (20
mL) at rt and under N2. The reaction mixture was stirred for
2.5 h and quenched with water (10 mL). The organic layer was
extracted three times with CH2Cl2. The organic extract was
washed with brine, dried over MgSO4, and filtered. The filtrate
was evaporated under reduced pressure. Crude 13 obtained
(957 mg) was used in the next step without further purification.
1H NMR (400 MHz, CDCl3): δ 1.24−1.35 (m, 14H), 1.47−
1.63 (m, 12H), 2.50 (t, J = 7.4 Hz, 2H), 3.38 (dt, J = 9.6, 6.7
Hz, 2H), 3.49 (m, 1H), 3.72 (dt, J = 9.6, 6.7 Hz, 1H), 3.87 (m,
1H), 4.57 (m, 1H), 6.13 (s, 1H).
(E)-13,14-Dichlorotetradec-13-en-1-ol (S3). p-TsOH (262
mg, 1.52 mmol) was added to a solution of alkene 13 (926 mg,
2.54 mmol) in MeOH (20 mL) at rt. The reaction mixture was
stirred for 1.5 h, then quenched with a saturated solution of
NaHCO3 (10 mL), and extracted three times with Et2O. The
organic layer was washed with a saturated solution of NaHCO3
several times, dried over MgSO4, and filtered. The filtrate was
evaporated under reduced pressure. The crude of S3 (819 mg)
was used in the next step without further purification. 1H NMR
(400 MHz, CDCl3): δ 1.24−1.34 (m, 14H), 1.41−1.51 (m,
4H), 1.52−1.62 (m, 2H), 2.50 (t, J = 7.4 Hz, 2H), 3.64 (t, J =
6.6 Hz, 2H), 6.13 (s, 1H). 13C NMR (101 MHz, CDCl3): δ
25.7 (t), 26.3 (t), 28.5 (t), 29.3 (t), 29.4 (t), 29.5 (t), 29.5 (t),
29.6 (t), 29.6 (t), 32.8 (t), 33.1 (t), 63.1 (t), 113.5 (d).
(E)-13,14-Dichlorotetradec-13-enal (S4). DMP (1.55 g, 3.5
mmol) was added to a solution of S3 (779 mg, 2.7 mmol) in
dry CH2Cl2 (20 mL) at rt and under N2. The reaction was
quenched with a saturated solution of NaHCO3, and the
saturated solution of NaS2O3 and the mixture were left stirring
for 20 min. The aqueous layer was extracted three times with
EtOAc, dried over MgSO4, and filtered. The filtrate was
evaporated under reduced pressure. The crude of S4 (605 mg)
was used in the next step without further purification. 1H NMR
(400 MHz, CDCl3): δ 1.29 (m, 14H), 1.44−1.66 (m, 4H), 2.35
(t, J = 7.5 Hz, 2H), 2.50 (t, J = 7.4 Hz, 2H), 6.13 (s, 1H), 9.76
(t, J = 2.0 Hz, 1H). 13C NMR (101 MHz, CDCl3): δ 22.1 (t),
26.3 (t), 28.5 (t), 29.1 (t), 29.3 (t), 29.3 (t), 29.4 (t), 29.4 (t),
29.5 (t), 33.1 (t), 43.9 (t), 113.5 (d), 136.6 (s), 203.0 (s).
(E)-13,14-Dichlorotetradec-13-enoic Acid (8). NaClO2
(734 mg, 8.12 mmol) was added to a solution of aldehyde
S4 (565 mg, 2.03 mmol) in tBuOH/H2O (14 mL/6 mL),
containing NaH2PO4 (1.21 g, 10.15 mmol) and 2-methyl-
butene (0.711 g, 10.15 mmol), at rt. The reaction mixture was
stirred for 2 h and 30 min. The reaction was quenched with
water and Na2S2O3. The organic phase was extracted three
times with EtOAc and washed with brine. The organic extract
was dried over MgSO4 and filtered, and the solvent was
removed under reduced pressure. Crude 8 (602 mg) was used
in the next step without further purification. 1H NMR (400
MHz, CDCl3): δ 1.31 (m, 14H), 1.45−1.62 (m, 4H), 2.35 (t, J
= 7.5 Hz, 2H), 2.49 (d, J = 7.4 Hz, 2H), 6.13 (s, 1H). 13C NMR
(101 MHz, chloroform-d): δ 24.7 (t), 26.3 (t), 28.5 (t), 29.0
(t), 29.2 (t), 29.4 (2C, t), 29.4 (t), 29.5 (t), 33.1 (t), 34.0 (t),
113.5 (d), 136.6 (s), 179.7 (s).
Methyl (E)-13,14-Dichlorotetradec-13-enoate (15).
TMSCHN2 (0.651 g, 5.7 mmol) was added to a solution of
acid 8 (0.562 g, 1.9 mmol) in dichloromethane (DCM)/
MeOH (9:1) at 0 °C and under N2. The reaction mixture was
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stirred for 3 h at 0−5 °C. The solvent was evaporated under
reduced pressure, and the residue was purified in preparative
RP-HPLC to obtain 15 (0.110 g, 0.35 mmol). Global yield
from 11 to 15: 12%. 1H NMR (400 MHz, CDCl3): δ 1.30 (m,
14H), 1.59−1.65 (m, 4H), 2.30 (t, J = 7.5 Hz, 4H), 2.50 (t, J =
7.4 Hz, 3H), 3.66 (s, 3H), 6.13 (s, 1H). 13C NMR (101 MHz,
CDCl3): δ 25.0 (t), 26.3 (t), 28.5 (t), 29.1 (t), 29.2 (t), 29.3
(t), 29.4 (t), 29.4 (t), 29.5 (t), 33.1 (t), 34.1 (t), 51.4 (q), 113.5
(d), 136.4 (s), 174.3 (s). HRMS (ESI+) m/z: calcd for
C15H27Cl2O2 (M + H), 309.1388; found, 309.1383.
tert-Butyl((2S)-2-((4S)-2-(4-methoxyphenyl)-1,3-dioxan-4-
yl)propoxy)dimethylsilane (S5). tert-Butyldimethylsilyl chlor-
ide (TBSCl; 1.25 g, 8.3 mmol) was added to a solution of
alcohol 166 (1.70 g, 6.7 mmol) and imidazole (684 mg, 10.1
mmol) in CH2Cl2 (60 mL). The reaction mixture was stirred
for 90 min. After this time, the mixture was washed with water,
dried over MgSO4, and filtered and the solvent was removed
under reduced pressure. Purification by silica gel column
chromatography with hexane/EtOAc (95:5) yielded S5 (2.0 g,
86%) as a colorless oil. 1H NMR (400 MHz, CDCl3): δ 0.05 (s,
3H), 0.05 (s, 3H), 0.91 (s, 9H), 1.00 (d, J = 6.9 Hz, 3H), 1.45
(dtd, J = 13.2, 2.4, 1.4 Hz, 1H), 1.78 (pt, J = 6.9, 5.1 Hz, 1H),
1.95 (tdd, J = 13.2, 12.3, 11.3, 5.1 Hz, 1H), 3.55 (dd, J = 9.9, 5.1
Hz, 1H), 3.64 (dd, J = 9.9, 6.9 Hz, 1H), 3.80 (s, 3H), 3.83−
4.01 (m, 2H), 4.27 (ddd, J = 11.3, 5.1, 1.4 Hz, 1H), 5.46 (s,
1H), 6.84−6.95 (m, 2H), 7.37−7.46 (m, 2H). 13C NMR (101
MHz, CDCl3): δ −5.4 (q), −5.4 (q), 11.9 (q), 18.3 (s), 25.9
(q), 28.7 (t), 40.6 (d), 55.2 (q), 64.5 (t), 67.2 (d), 77.4 (d),
101.0, 113.4 (d), 127.2 (d), 131.7 (s), 159.7 (s). HRMS (ESI+)
m/z: calcd for C20H34NaO4Si [M + Na]
+, 389.2119; found,
389.2111.
( 3S , 4S ) - 5 - ( ( t e r t -Bu ty ld ime thy l s i l y l ) oxy ) - 3 - ( ( 4 -
methoxybenzyl)oxy)-4-methylpentan-1-ol (S6). A solution of
diisobutylaluminium hydride 1 M in heptane (1.3 mL, 1.3
mmol) was added to a solution of S5 (355 mg, 0.97 mmol) in
CH2Cl2 (15 mL) at −20 °C. The reaction mixture was stirred
at 0 °C for 2 h. Then, a saturated solution of Rochelle’s salt (15
mL) was added, and the mixture was stirred for 1 h until the
formation of two layers. The organic solution was dried over
Na2SO4 and filtered, and the solvent was removed under
reduced pressure. Purification by silica gel column chromatog-
raphy with hexane/EtOAc (8:2) yielded S6 (285 mg, 90% br s
m) as a colorless oil and 43 mg of recovered starting material.
1H NMR (400 MHz, CDCl3): δ 0.05 (s, 6H), 0.90 (s, 9H), 0.95
(d, J = 6.9 Hz, 3H), 1.67−1.83 (m, 2H), 1.85−2.00 (m, 1H),
2.17 (m, 1H), 3.50 (dd, J = 9.9, 6.9 Hz, 1H), 3.62−3.78 (m,
4H), 3.80 (s, 3H), 4.46 (d, J = 11.0 Hz, 1H), 4.55 (d, J = 11.0
Hz, 1H), 6.83−6.92 (m, 2H), 7.22−7.31 (m, 2H). 13C NMR
(101 MHz, CDCl3): δ −5.4 (q), −5.4 (q), 12.6 (q), 18.3 (s),
25.9 (q), 33.6 (t), 39.0 (d), 55.3 (q), 61.2 (t), 64.7 (t), 71.9 (t),
79.2 (d), 113.8 (d), 129.5 (d), 130.7 (s), 159.2 (s). HRMS (ESI
+) m/z: calcd for C20H37O4Si [M + H]
+, 369.2456; found,
369.2446.
( 3S , 4S ) - 5 - ( ( t e r t -Bu ty ld ime thy l s i l y l ) oxy ) - 3 - ( ( 4 -
methoxybenzyl)oxy)-4-methylpentanal (17). DMSO (0.031
mL, 0.44 mmol) was added to a solution of oxalyl chloride
(0.019 mL, 0.22 mmol) in CH2Cl2 (2 mL) at −78 °C, and the
reaction mixture was stirred for 30 min. A solution of alcohol
S6 (40 mg, 0.11 mmol) in CH2Cl2 (1 mL) was added, and the
mixture was stirred for 45 min at the same temperature. Et3N
(0.123 mL, 0.88 mmol) was added, and the reaction mixture
was stirred for 30 min at 0 °C. Then, it was quenched with
NH4Cl saturated solution and extracted with CH2Cl2. The
organic layer was washed with brine, dried over MgSO4, and
evaporated. Purification by silica gel chromatography with
hexane/EtOAc (9:1) yielded aldehyde 17 (32 mg, 80%) as a
colorless oil. 1H NMR (400 MHz, CDCl3): δ 0.05 (2s, 6H),
0.90 (s, 9H), 0.93 (d, J = 7.0 Hz, 3H), 1.81−1.92 (m, 1H), 2.56
(ddd, J = 16.4, 4.6, 2.0 Hz, 1H), 2.71 (ddd, J = 16.4, 7.8, 2.0 Hz,
1H), 3.53 (dd, J = 10.0, 5.7 Hz, 1H), 3.61 (dd, J = 10.0, 6.5 Hz,
1H), 3.80 (s, 3H), 4.03−4.10 (m, 1H), 4.49 (s, 2H), 6.83−6.88
(m, 2H), 7.20−7.25 (m, 2H), 9.76 (t, J = 2.0 Hz, 1H). 13C
NMR (101 MHz, CDCl3): δ −5.5 (q), −5.4 (q), 12.1 (q), 18.2
(s), 25.9 (q), 39.7 (d), 46.6 (t), 55.3 (q), 64.5 (t), 72.0 (t), 74.8
(d), 113.8 (d), 129.3 (d), 130.5 (s), 159.2 (s), 201.9 (s).





en-3-one (18). A solution of silylenolether (E)-((4-bromo-3-
methoxybuta-1,3-dien-2-yl)oxy)trimethylsilane6 (527 mg, 2.1
mmol) in CH2Cl2 (10 mL) was added to a cooled (−78 °C)
solution of aldehyde 17 (503 mg, 1.37 mmol) in CH2Cl2 (30
mL), and then BF3·OEt2 (155 μL, 1.26 mmol) was added
dropwise. The reaction was stirred at −78 °C for 60 min,
quenched with the saturated solution of NaHCO3 (30 mL),
and extracted three times with CH2Cl2. The organic solution
was dried over Na2SO4, filtrated, and concentrated under
reduced pressure. Purification by silica gel column chromatog-
raphy with hexane/EtOAc (8:2) afforded 18 (312 mg, 47%) as
an 82:17 mixture of diastereomers. Mayor diastereomer data:
1H NMR (400 MHz, CDCl3): δ 0.04 (s, 6H), 0.89 (s, 9H), 0.94
(d, J = 6.9 Hz, 3H), 1.60−1.64 (m, 2H), 1.87−1.93 (m, 1H),
2.76−2.85 (m, 2H), 3.44−3.52 (m, 1H), 3.63 (s, 3H), 3.66 (dd,
J = 9.9, 5.8 Hz, 1H), 3.80 (s, 3H), 3.80−3.81 (m, 1H), 4.23−
4.35 (m, 1H), 4.46−4.57 (m, 2H), 5.66 (s, 1H), 6.82−6.89 (m,
2H), 7.24−7.28 (m, 2H). 13C NMR (101 MHz, CDCl3): δ
−5.4 (q), −5.3 (q), 12.5 (q), 18.3 (s), 25.9 (q), 38.3 (t), 39.4
(d), 47.1 (t), 55.3 (q), 56.0 (q), 64.7 (d), 64.8 (t), 72.4 (t),
76.8 (d), 84.4 (d), 113.8 (d), 129.5 (d), 130.9 (s), 152.9 (s),
159.2 (s), 197.7 (s). HRMS (ESI+) m/z: calcd for
C25H41BrNaO6Si [M + Na]
+, 567.1748; found, 567.1744.
(5S,7S,8S,E)-1-Bromo-9-((tert-butyldimethylsilyl)oxy)-2-
methoxy -7 - ( (4 -methoxybenzy l )oxy ) -8 -methy l -5 -
((triethylsilyl)oxy)non-1-en-3-one (S7). Imidazole (140 mg, 2
mmol), TESCl (0.14 mL, 0.85 mmol), and DMAP (6 mg, 0.05
mmol) were added sequentially to a solution of 18 (290 mg,
0.53 mmol) in CH2Cl2 (10 mL). The cloudy solution was
stirred 45 min until the TLC analysis showed complete
conversion of the starting material. The reaction was quenched
with the saturated solution of NH4Cl (10 mL) and extracted
three times with CH2Cl2. The organic layers were dried over
MgSO4 and filtered, and the solvent was evaporated under
reduced pressure. Purification with deactivated (1% Et3N) silica
gel column chromatography with hexane/EtOAc (95:5)
afforded S7 (300 mg, 86%) as a colorless oil. 1H NMR (400
MHz, CDCl3): δ 0.03 (s, 6H), 0.56−0.63 (m, 6H), 0.89 (s,
9H), 0.89−0.96 (m, 12H), 1.68 (dt, J = 6.6, 5.4 Hz, 2H), 1.89
(qd, J = 6.9, 3.2 Hz, 1H), 2.78 (dd, J = 16.3, 5.4 Hz, 1H), 2.95
(dd, J = 16.3, 6.6 Hz, 1H), 3.41 (dd, J = 9.8, 7.0 Hz, 1H), 3.59
(s, 3H), 3.61−3.67 (m, 2H), 3.80 (s, 3H), 4.31−4.38 (m, 1H),
4.39−4.51 (m, 2H), 5.58 (s, 1H), 6.83−6.88 (m, 2H), 7.22−
7.26 (m, 2H). HRMS (ESI+) m/z: calcd for C31H56BrO6Si2 [M
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5-((triethylsilyl)oxy)non-1-ene (S8). A solution of the Tebbe
reagent in toluene (0.5 M, 3.62 mL, 1.81 mmol) was added to a
solution of S7 (290 mg, 0.45 mmol) and pyridine (0.150 mL,
1.81 mmol) in THF (12 mL) at 0 °C. The reaction mixture was
warmed to rt and then heated up at 50 °C for 90 min. Then, it
was quenched at rt with the saturated solution of Rochelle’s salt
(3 mL) and extracted three times with Et2O. The organic phase
was dried over MgSO4 and filtered, and the solvent was
evaporated under reduced pressure. Purification by silica gel
column chromatography with hexane/EtOAc (95:5) yielded
alkene S8 (235 mg, 81%) as a colorless oil. 1H NMR (400
MHz, CDCl3): δ 0.03 (s, 6H), 0.54−0.64 (m, 6H), 0.87−0.90
(m, 12H), 0.92−0.97 (m, 9H), 1.43−1.50 (m, 1H), 1.76−1.85
(m, 1H), 1.92 (qd, J = 6.8, 3.2 Hz, 1H), 2.29 (dd, J = 13.8, 9.0
Hz, 1H), 2.61 (dd, J = 13.8, 4.2 Hz, 1H), 3.41 (dd, J = 9.8, 7.2
Hz, 1H), 3.49 (s, 3H), 3.62−3.72 (m, 2H), 3.80 (s, 3H), 3.88−
3.96 (m, 1H), 4.42 (d, J = 11.1 Hz, 1H), 4.50 (d, J = 11.1 Hz,
1H), 5.26 (s, 1H), 5.33 (s, 1H), 5.38 (s, 1H), 6.79−6.88 (m,
2H), 7.23−7.26 (m, 2H). 13C NMR (101 MHz, CDCl3): δ 5.3
(t), 7.2 (q), 12.1 (q), 26.1 (q), 38.9 (t), 39.4 (d), 43.4 (t), 55.3
(q), 55.4 (q), 65.1 (t), 68.5 (d), 71.0 (t), 77.0 (d), 78.4 (d),
113.5 (d), 121.3 (t), 128.6 (d). HRMS (ESI+) m/z: calcd for
C32H58BrO5Si2 [M + H]
+, 657.3001; found, 657.2991.
(5R,7S,8S,E)-1-Bromo-9-((tert-butyldimethylsilyl)oxy)-2-
methoxy-7-((4-methoxybenzyl)oxy)-8-methyl-3-methylene-
non-1-en-5-ol (19). PPTS (17 mg, 0.07 mmol) was added to a
solution of S8 (235 mg, 0.357 mmol) in MeOH (13 mL) at 0
°C, and the reaction mixture was stirred for 45 min at rt. After
this time, the reaction mixture was quenched with the saturated
solution of NaHCO3 (5 mL) and extracted three times with
CH2Cl2. The organic phase was dried over MgSO4 and filtered,
and the solvent was evaporated under reduced pressure.
Purification by silica gel column chromatography with
hexane/EtOAc (85:15) yielded alcohol 19 (170 mg, 88%) as
a colorless oil (mixture of isomers). Separation of diastereomers
was performed at this point via silica column chromatography.
1H NMR (400 MHz, CDCl3): δ 0.04 (s, 6H), 0.90 (s, 9H), 0.94
(d, J = 6.9 Hz, 3H), 1.52−1.65 (m, 2H), 1.84−1.93 (m, 1H),
2.28 (dd, J = 13.8, 9.0 Hz, 1H), 2.44 (dd, J = 13.8, 4.0 Hz, 1H),
3.46 (dd, J = 9.9, 6.9 Hz, 1H), 3.56 (s, 3H), 3.67 (dd, J = 9.9,
5.8 Hz, 1H), 3.80 (s, 3H), 3.83 (s, 1H), 3.86 (s, 1H), 4.48 (d, J
= 10.9 Hz, 1H), 4.54 (d, J = 10.9 Hz, 1H), 5.32 (s, 1H), 5.38 (s,
2H), 6.84−6.89 (m, 2H), 7.25−7.28 (m, 2H). 13C NMR (101
MHz, CDCl3): δ −5.4 (q), −5.3 (q), 12.5 (q), 18.3 (s), 25.9
(q), 38.4 (t), 39.5 (d), 43.1 (t), 55.3 (q), 55.6 (q), 64.9 (t),
66.5 (d), 72.5 (t), 77.1 (d), 78.6 (d), 113.8 (d), 122.1 (t), 129.5
(d), 131.1 (s), 139.7 (s), 159.1 (s), 159.1 (s). HRMS (ESI+)
m/z: calcd for C26H43BrNaO5Si [M + Na]
+, 565.1955; found,
565.1943.
General Procedure for Derivatization with MPA. α-
MPA (5 equiv) and 1-ethyl-3-(3-dimethylaminopropyl)-
carbodiimide (EDC)·HCl (5 equiv) were added to a solution
of alcohol 10(5R) (1 equiv) in THF, then DMAP (0.1 equiv)
was added, and the solution was stirred for 2 h at 40 °C. The
solution was filtered through Celite 545, poured into Et2O, and
washed with NH4Cl saturated solution. The organic residue
was dried over Na2SO4 and filtered, and the solvent was
removed under reduced pressure. Purification by silica gel
column chromatography with hexane/EtOAc (90:10) yielded




19 (4 mg, 0.007 mmol) and (R)-MPA (5 equiv) afforded (R)-
MPA ester S9 (4 mg, 83%). 1H NMR (400 MHz, CDCl3): δ
0.01 (s, 6H), 0.67 (d, J = 6.9 Hz, 3H), 0.88 (s, 9H), 1.55−1.58
(m, 2H), 1.64−1.69 (m, 1H), 2.49 (dd, J = 14.5, 6.4 Hz, 1H),
2.58 (dd, J = 14.5, 5.8 Hz, 1H), 2.79 (dt, J = 8.5, 3.9 Hz, 1H),
3.21−3.32 (m, 1H), 3.41 (s, 3H), 3.49−3.52 (m, 1H), 3.53 (s,
3H), 3.79 (s, 3H), 3.85 (d, J = 10.3 Hz, 1H), 4.07 (d, J = 10.3
Hz, 1H), 4.72 (s, 1H), 5.18−5.26 (m, 1H), 5.30 (s, 1H), 5.33
(d, J = 1.4 Hz, 1H), 5.42 (d, J = 1.4 Hz, 1H), 6.81−6.85 (m,
2H), 7.15−7.20 (m, 2H), 7.30−7.37 (m, 3H), 7.43−7.47 (m,
2H). HRMS (ESI+) m/z: calcd for C35H55BrNO7Si [M +
NH4]




19 (4 mg, 0.007 mmol) and (S)-MPA (5 equiv) afforded (S)-
MPA ester S10 (5 mg, quant.). 1H NMR (400 MHz, CDCl3): δ
0.04 (s, 6H), 0.86 (d, J = 6.9 Hz, 3H), 0.90 (s, 9H), 1.68−1.74
(m, 2H), 1.76−1.83 (m, 1H), 2.35 (dd, J = 14.5, 5.7 Hz, 1H),
2.47 (dd, J = 14.5, 6.7 Hz, 1H), 3.32−3.36 (m, 1H), 3.38−3.41
(m, 1H), 3.41 (s, 3H), 3.45 (s, 3H), 3.61 (dd, J = 9.8, 6.0 Hz,
1H), 3.79 (s, 3H), 4.20 (d, J = 10.5 Hz, 1H), 4.32 (d, J = 10.5
Hz, 1H), 4.72 (s, 1H), 5.03 (d, J = 1.4 Hz, 1H), 5.21 (s, 3H),
6.82−6.86 (m, 2H), 7.22−7.26 (m, 2H), 7.30−7.35 (m, 3H),
7.42−7.47 (m, 2H). HRMS (ESI+) m/z: calcd for
C35H55BrNO7Si [M + NH4]
+, 708.2926; found, 708.2921.
(5S,7S,8S,E)-1-Bromo-9-((tert-butyldimethylsilyl)oxy)-2-
methoxy-7-((4-methoxybenzyl)oxy)-8-methyl-3-methylene-
non-1-en-5-ol (20). Diisopropyl azodicarboxylate (DIAD; 0.22
mL, 1.06 mmol) was slowly added to a solution of 19 (105 mg,
0.19 mmol), p-nitrobenzoic acid (170 mg, 1 mmol), and PPh3
(294 mg, 1 mmol) in benzene (8 mL), and the yellowish
solution was stirred for 4 h at 40 °C. The reaction mixture was
quenched with the saturated solution of NaHCO3 (10 mL) and
extracted three times with Et2O. The organic layer was dried
over MgSO4, filtered, and evaporated under reduced pressure.
The crude was filtered through a plug of silica using hexane/
EtOAc 9:1 to eliminate the p-nitrobenzoic acid and PPh3O (Rf
= 0.1). After evaporation, the resulting crude was dissolved in
MeOH (10 mL), K2CO3 (180 mg, 1.30 mmol) was added, and
the mixture was stirred for 2 h until TLC indicated total
hydrolysis. The reaction mixture was quenched with the
saturated solution of NH4Cl (10 mL) and extracted three times
with AcOEt. The organic layer was dried over MgSO4, filtered,
evaporated under reduced pressure, and purified by silica gel
column chromatography with hexane/EtOAc 9:1 to obtain 20
as a colorless oil (60 mg, 59% for two steps). 1H NMR (400
MHz, CDCl3): δ 0.05 (s, 6H), 0.90 (s, 9H), 0.92 (d, J = 7.0 Hz,
3H), 1.59−1.72 (m, 2H), 1.91−2.00 (m, 1H), 2.35 (dd, J =
13.8, 6.4 Hz, 1H), 2.45 (dd, J = 13.8, 6.8 Hz, 1H), 3.46−3.51
(m, 1H), 3.57 (s, 3H), 3.67 (dd, J = 9.9, 5.9 Hz, 1H), 3.71−
3.77 (m, 2H), 3.79 (s, 3H), 4.43 (d, J = 10.9 Hz, 1H), 4.55 (d, J
= 10.9 Hz, 1H), 5.31 (s, 1H), 5.36 (s, 2H), 6.84−6.89 (m, 2H),
7.22−7.27 (m, 2H). 13C NMR (101 MHz, CDCl3): δ −5.4 (q),
−5.3 (q), 12.3 (q), 18.3 (s), 25.9 (q), 37.3 (t), 38.7 (d), 42.6
(t), 55.3 (q), 55.6 (q), 64.5 (t), 69.3 (d), 71.5 (t), 78.6 (d),
80.2 (d), 113.8 (d), 121.8 (t), 129.4 (d), 130.5 (s), 139.5 (s),
159.0 (s), 159.2 (s). HRMS (ESI+) m/z: calcd for
C26H43BrNaO5Si [M + Na]




(E)-13,14-Dichlorotetradec-13-enoic acid (8) (82 mg, 0.28
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mmol) was added to a solution of EDC·HCl (268 mg, 1.4
mmol), Et3N (0.195 mL, 1.4 mmol), and DMAP (171 mg, 1.4
mmol) in CH2Cl2 (3 mL), and the solution was stirred for 20
min. Alcohol 20 (50 mg, 0.092 mmol) dissolved in CH2Cl2 (2.5
mL) was added, and the solution was stirred for 16 h. The
reaction mixture was quenched with the saturated solution of
NH4Cl (8 mL) and extracted three times with AcOEt. The
organic layer was dried over MgSO4, filtered, evaporated under
reduced pressure, and purified by silica gel column chromatog-
raphy with hexane/EtOAc 95:5 to obtain ester 21 as a colorless
oil (35 mg, 56% br s m) and recovered 20 (8 mg). 1H NMR
(400 MHz, CDCl3): δ 0.03 (s, 6H), 0.86 (d, J = 6.9 Hz, 3H),
0.88 (s, 9H), 1.25−1.31 (m, 14H), 1.55 (s, 4H), 1.76−1.91 (m,
3H), 2.23 (td, J = 7.6, 3.8 Hz, 2H), 2.47−2.59 (m, 4H), 3.44
(dd, J = 9.8, 6.5 Hz, 1H), 3.54 (s, 3H), 3.56−3.62 (m, 2H),
3.80 (s, 3H), 4.41 (d, J = 11.1 Hz, 1H), 4.48 (d, J = 11.1 Hz,
1H), 5.00 (p, J = 6.5 Hz, 1H), 5.31 (s, 1H), 5.34 (d, J = 1.3 Hz,
1H), 5.41 (d, J = 1.3 Hz, 1H), 6.13 (s, 1H), 6.84−6.88 (m,
2H), 7.25−7.27 (m, 2H). 13C NMR (101 MHz, CDCl3): δ
−5.4 (q), −5.4 (q), 11.0 (q), 18.2 (s), 24.9 (t), 25.9 (q), 26.3
(t), 28.5 (t), 29.2 (t), 29.3 (t), 29.3 (t), 29.5 (t, 2C), 29.5 (t),
33.1 (t), 34.5 (t), 35.3 (t), 38.8 (t + d, 2C), 55.3 (q), 55.6 (q),
64.9 (t), 70.0 (d), 71.2 (t), 75.7 (d), 78.7 (d), 113.5 (d), 113.6
(d), 122.0 (t), 129.1 (d), 131.2 (s), 136.6 (s), 138.4 (s), 141.7
(s), 158.5 (s), 173.0 (s). HRMS (ESI+) m/z: calcd for
C40H69BrCl2NO6Si [M + NH4]
+, 836.3449; found, 836.3439.
(5S,7S,8S,E)-1-Bromo-9-hydroxy-2-methoxy-7-((4-
methoxybenzyl)oxy)-8-methyl-3-methylenenon-1-en-5-yl-
(E)-13,14-dichlorotetradec-13-enoate (S11). A 1 M TBAF
solution (0.071 mL, 0.071 mmol) was added to a solution of 21
(29 mg, 0.035 mmol) in THF (0.7 mL), and the solution was
stirred at rt for 6 h. The reaction mixture was quenched with
the saturated solution of NH4Cl (1 mL) and extracted three
times with Et2O. The organic layer was dried over MgSO4,
filtered, evaporated under reduced pressure, and purified by
silica gel column chromatography with hexane/EtOAc 7:3 to
obtain alcohol S11 as a colorless oil (19 mg, 77%). 1H NMR
(400 MHz, CDCl3): δ 0.87 (d, J = 7.1 Hz, 3H), 1.25−1.31 (m,
14H), 1.55−1.59 (m, 4H), 1.78−1.86 (m, 1H), 1.87−1.95 (m,
1H), 2.04−2.08 (m, 1H), 2.19−2.28 (m, 2H), 2.46−2.56 (m,
4H), 3.56 (s, 3H), 3.50−3.64 (m, 3H), 3.80 (s, 3H), 4.40−4.52
(m, 2H), 5.02 (p, J = 6.5 Hz, 1H), 5.32 (s, 1H), 5.35 (d, J = 1.4
Hz, 1H), 5.43 (d, J = 1.4 Hz, 1H), 6.13 (s, 1H), 6.85−6.89 (m,
2H), 7.24−7.27 (m, 2H). 13C NMR (101 MHz, CDCl3): δ 11.2
(q), 24.9 (t), 26.3 (t), 28.5 (d), 29.2 (t), 29.3 (t), 29.3 (t), 29.5
(t), 29.5 (t), 33.1 (t), 34.3 (t), 34.6 (t), 36.9 (d), 39.2 (t), 55.3
(q), 55.6 (q), 66.0 (t), 69.8 (d), 70.9 (t), 77.8 (d), 78.8 (d),
113.5 (d), 113.8 (d), 122.2 (t), 129.4 (d), 130.3 (s), 134.4 (s),
138.2 (s), 158.3 (s), 159.2 (s), 173.3 (s). HRMS (ESI+) m/z:





chlorotetradec-13-enoate (5). NaHCO3 (4 mg, 0.047 mmol)
and DMP (5 mg, 0.118 mmol) were added to a solution of S11
(2.5 mg, 0.0035 mmol) in CH2Cl2 (0.8 mL), and the solution
was stirred for 30 min. The reaction mixture was diluted with
Et2O (10 mL) and quenched with saturated solutions of
NaHCO3 and Na2S2O3 (2 + 2 mL). The crude was extracted
twice with Et2O, and the organic extracts were dried over
Na2SO4, filtered, and concentrated under reduced pressure.
Purification by silica gel column chromatography with hexane/
EtOAc (8:2) yielded aldehyde 5 (2.3 mg, 93%) as a colorless
oil. 1H NMR (400 MHz, CDCl3): δ 1.11 (d, J = 7.0 Hz, 3H),
1.27 (s, 14H), 1.56 (s, 4H), 1.85 (ddd, J = 14.5, 7.5, 4.2 Hz,
1H), 1.98 (ddd, J = 14.5, 8.5, 5.8 Hz, 1H), 2.19−2.27 (m, 2H),
2.46−2.61 (m, 5H), 3.56 (s, 3H), 3.79 (s, 3H), 3.91 (ddd, J =
7.5, 5.8, 3.0 Hz, 1H), 4.37 (d, J = 11.2 Hz, 1H), 4.44 (d, J =
11.2 Hz, 1H), 4.94−5.05 (m, 1H), 5.33 (s, 1H), 5.36 (s, 1H),
5.44 (s, 1H), 6.13 (s, 1H), 6.83−6.88 (m, 2H), 7.18−7.23 (m,
2H), 9.64 (s, 1H). 13C NMR (101 MHz, CDCl3): δ 7.5 (q),
24.9 (t), 26.3 (t), 28.5 (t), 29.2 (t), 29.3 (d), 29.5 (t), 29.5 (t),
33.1 (t), 34.5 (t), 35.3 (t), 39.2 (t), 49.2 (d), 55.3 (q), 55.6 (q),
69.3 (d), 70.8 (t), 74.3 (d), 78.9 (d), 113.5 (d), 113.8 (d),
122.4 (t), 129.3 (d), 130.1 (s), 136.6 (s), 138.0 (s), 158.2 (s),
159.2 (s), 173.6 (s), 204.1 (s). HRMS (ESI+) m/z: calcd for
C34H53BrCl2NO6 [M + NH4]
+, 720.2428; found, 720.2447.
(E)-4-Hydroxy-7-iodo-3,3,6-trimethylhept-6-en-2-one (24).
A solution of silylenolether 2214 (1.15 g, 7.3 mmol) in CH2Cl2
(10 mL) was added to a cooled solution (−78 °C) of aldehyde
2323 (1.26 g, 6 mmol) in CH2Cl2 (65 mL). BF3·OEt2 (0.58 mL,
4.71 mmol) was added dropwise. The reaction mixture was
stirred at −78 °C for 2 h and quenched with the saturated
solution of NaHCO3 (75 mL). The residue was extracted three
times with CH2Cl2, dried over Na2SO4, filtrated, and
concentrated under reduced pressure. Purification by silica gel
column chromatography with hexane/EtOAc (8:2) afforded
1.13 g of 24 (63%) as a racemic mixture. 1H NMR (400 MHz,
CDCl3): δ 1.14 (s, 3H), 1.17 (s, 3H), 1.89 (d, J = 0.9 Hz, 3H),
2.18 (s, 3H), 2.22−2.32 (m, 2H), 3.80−3.90 (m, 1H), 6.03 (q, J
= 0.9 Hz, 1H). 13C NMR (101 MHz, CDCl3): δ 19.6 (q), 21.6
(q), 23.9 (q), 26.4 (q), 41.9 (t), 51.5 (s), 73.4 (d), 77.2 (d),
145.0 (s), 214.5 (s). HRMS (ESI+) m/z: calcd for C10H18IO2
[M + H]+, 297.0346; found, 297.0340.
(R,E)-1-Iodo-2,5,5-trimethyl-6-oxohept-1-en-4-yl-(R)-2-me-
thoxy-2-phenylacetate (25). (R)-(−)-α-MPA (565 mg, 3.4
mmol) and EDC·HCl (862 mg, 4.5 mmol) were added to a
solution of alcohol 24 (596 mg, 2 mmol) in THF (15 mL),
then DMAP (60 mg, 0.5 mmol) was added, and the solution
was stirred at 45 °C for 16 h. The solution was poured into
Et2O (15 mL) and washed with NH4Cl saturated solution (2 ×
15 mL). The organic residue was dried over Na2SO4 and
filtered, and the solvent was removed under reduced pressure.
Purification by silica gel column chromatography with hexane/
EtOAc (90:10) yielded the corresponding esters 25-R,R (366
mg, 41%) and 25-R,S (375 mg, 42%) as colorless oils.
25-R,R Characterization. 1H NMR (400 MHz, CDCl3): δ
0.81 (s, 3H), 0.94 (s, 3H), 1.89 (d, J = 0.8 Hz, 3H), 1.90 (s,
3H), 2.20−2.35 (m, 2H), 3.43 (s, 3H), 4.65 (s, 1H), 5.36 (dd, J
= 10.3, 2.5 Hz, 1H), 5.88 (br s, 1H), 7.31−7.42 (m, 5H). 13C
NMR (101 MHz, CDCl3): δ 19.6 (q), 21.4 (q), 23.5 (q), 26.0
(q), 40.7 (t), 51.1 (s), 58.0 (q), 74.5 (d), 77.7 (d), 82.6 (d),
127.3 (d), 128.7 (d), 128.9 (d), 136.3 (s), 143.9 (s), 169.7 (s),
210.7 (s). HRMS (ESI+) m/z: calcd for C19H25INaO4 [M +
Na]+, 467.0690; found, 467.0692.
25-R,S Characterization. 1H NMR (400 MHz, CDCl3): δ
1.05 (s, 3H), 1.12 (s, 3H), 1.76 (d, J = 1.1 Hz, 3H), 2.12 (s,
3H), 2.13−2.15 (m, 2H), 3.40 (s, 3H), 4.69 (s, 1H), 5.33 (d, J
= 1.1 Hz, 1H), 5.40 (t, J = 6.0 Hz, 1H), 7.32−7.40 (m, 5H).
(R,E)-6-Iodo-2,5-dimethyl-2-(2-methyl-1,3-dioxolan-2-yl)-
hex-5-en-3-yl-(R)-2-methoxy-2-phenylacetate (S12). Trime-
thylsilyl trifluoromethanesulfonate (TMSOTf; 15 μL, 0.08
mmol) was added over a solution of ketone 25-R,R (360 mg,
0.81 mmol) and 1,2-bis(trimethylsiloxy)ethane (500 mg, 2.43
mmol) in CH2Cl2 at −78 °C, and the mixture was left to evolve
to rt and stirred at rt for additional 48 h. The reaction mixture
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was quenched with 0.1 mL of pyridine, and the solvent was
removed under reduced pressure. Purification by silica gel
column chromatography with hexane/EtOAc (90:10) yielded
ketal S12 (335 mg, 97%) as a colorless oil. 1H NMR (400
MHz, CDCl3): δ 0.62 (s, 3H), 0.73 (s, 3H), 1.12 (s, 3H), 1.87
(s, 3H), 2.43 (dd, J = 14.3, 11.3 Hz, 1H), 2.68 (dd, J = 14.3, 1.9
Hz, 1H), 3.43 (s, 3H), 3.69−3.88 (m, 4H), 4.63 (s, 1H), 5.19
(dd, J = 11.3, 1.9 Hz, 1H), 5.88 (s, 1H), 7.28−7.43 (m, 5H).
13C NMR (101 MHz, CDCl3): δ 17.7 (q), 20.0 (q), 20.5 (q),
23.6 (q), 41.4 (t), 45.8 (s), 58.2 (q), 64.4 (t), 64.7 (t), 75.0 (d),
76.9 (d), 82.7 (d), 112.4 (s), 127.4 (d), 128.4 (d), 128.6 (s),
136.5 (s), 145.1 (s), 169.7 (s). HRMS (ESI+) m/z: calcd for
C21H29INaO5 [M + Na]
+, 511.0952; found, 511.0962.
(R,E)-6-Iodo-2,5-dimethyl-2-(2-methyl-1,3-dioxolan-2-yl)-
hex-5-en-3-ol (26). LiOH·H2O (315 mg, 8.3 mmol) was added
to a solution of S12 (320 mg, 0.65 mmol) in MeOH (8 mL),
and the solution was stirred at 65 °C for 16 h. The reaction
mixture was added to a separatory funnel containing Et2O (10
mL) and H2O (10 mL), and it was extracted two times with
Et2O (10 mL). The organic layer was washed with NaHCO3
saturated solution (15 mL) and dried over MgSO4, and the
solvent was evaporated under reduced pressure yielding alcohol




amine (0.33 mL, 2.4 mmol) and TBSOTf (0.23 mL, 1
mmol) were sequentially added to a solution of crude alcohol
26 (205 mg, 0.60 mmol) in CH2Cl2 (8 mL) at −20 °C, and the
mixture was stirred for 15 min at −20 °C and then 60 min at rt.
The reaction mixture was quenched with NH4Cl saturated
solution (10 mL), extracted with CH2Cl2 (2 × 10 mL), and
dried over MgSO4, and the solvent was removed under reduced
pressure. Purification by silica gel column chromatography with
hexane/EtOAc (95:5) yielded S13 (200 mg, 68% for two steps)
as a colorless oil. 1H NMR (400 MHz, CDCl3): δ −0.05 (s,
3H), 0.03 (s, 3H), 0.88 (s, 9H), 0.94 (s, 3H), 0.97 (s, 3H), 1.29
(s, 3H), 1.82 (s, 3H), 2.32 (dd, J = 14.5, 9.0 Hz, 1H), 2.88 (dd,
J = 14.5, 2.1 Hz, 1H), 3.70 (dd, J = 9.0, 2.1 Hz, 1H), 3.81−3.96
(m, 4H), 5.91 (s, 1H). 13C NMR (101 MHz, CDCl3): δ −3.5
(q), −3.2 (q), 18.4 (q), 20.8 (q), 23.0 (q), 23.9 (q), 26.2 (q),
30.3 (s), 45.0 (t), 47.4 (s), 64.3 (t), 64.7 (t), 75.2 (d), 77.9 (d),
113.2 (s), 145.8 (s). HRMS (ESI+) m/z: calcd for
C18H35INaO3Si [M + Na]
+, 477.1298; found, 477.1299.
(R,E)-4-((tert-Butyldimethylsilyl)oxy)-7-iodo-3,3,6-trime-
thylhept-6-en-2-one (9). PTSA·H2O (3.8 mg, 0.02 mmol) was
added to a solution of S13 (66 mg, 0.15 mmol) in acetone (5
mL), and the reaction mixture was stirred at rt for 30 min.
Then, it was quenched with two drops of triethylamine, and the
solvent was removed under reduced pressure. Purification by
silica gel column chromatography with hexane/EtOAc (95:5)
yielded enantiopure ketone 9 (59 mg, quant.) as a colorless oil.
1H NMR (400 MHz, CDCl3): δ −0.01 (s, 3H), 0.02 (s, 3H),
0.87 (s, 9H), 1.10 (s, 6H), 1.82 (s, 3H), 2.14 (s, 3H), 2.21−
2.24 (m, 2H), 4.05−4.09 (m, 1H), 5.94 (s, 1H). 13C NMR (101
MHz, CDCl3): δ −4.0 (q), −3.7 (q), 18.2 (s), 19.6 (q), 22.9
(q), 23.8 (q), 26.0 (q), 27.1 (q), 44.8 (t), 53.0 (s), 74.0 (d),
78.8 (d), 144.5 (s), 213.4 (s). HRMS (ESI+) m/z: calcd for
C16H31INaO2Si [M + Na]





en-3-one (6). DMF was degassed using a freeze-thaw-pump
technique. CrCl2 and NiCl2 were weighted in a glovebox. A
mixture of iodoalkene 9 (52 mg, 0.13 mmol) and aldehyde 45
(50 mg, 0.083 mmol) in DMF (0.5 + 0.2 mL rinse) was
cannulated to a solution of CrCl2 (202 mg, 1.64 mmol) and
NiCl2 (2 mg, 1 m/m % CrCl2) in DMF (1 mL), and the
solution was stirred at rt for 48 h. The reaction mixture was
filtered through Celite and washed with Et2O. The organic
ethereal phase was washed with H2O (2 × 10 mL) and brine
(10 mL) and dried over MgSO4, and the solvent was removed
under reduced pressure. Purification by silica gel column
chromatography with hexane/EtOAc (8:2) yielded alcohol 6
(13.5 mg, 19%) as a single diastereomer as a colorless oil. 1H
NMR (400 MHz, CDCl3): δ 0.02 (s, 3H), 0.04 (s, 3H), 0.05 (s,
3H), 0.06 (s, 3H), 0.85 (s, 9H), 0.87 (s, 9H), 0.91 (d, J = 6.1
Hz, 3H), 1.03 (br s, 21H), 1.09 (s, 3H), 1.12 (s, 3H), 1.27 (m,
1H), 1.42 (m, 1H), 1.60 (m, 1H), 1.70 (m, 1H), 1.71 (s, 3H),
1.72 (s, 3H), 1.91 (m, 1H), 2.03−2.11 (m, 2H), 2.11 (m, 1H),
2.14 (s, 3H), 2.24 (m, 1H), 2.39 (m, 1H), 2.50 (m, 1H), 2.70
(m, 1H), 2.73 (m, 1H), 3.89 (dd, J = 4.6, 1.3 Hz, 1H), 4.06 (m,
1H), 4.19 (t, J = 6.1 Hz, 1H), 4.33 (m, 1H), 4.43 (m, 1H), 5.05
(m, 1H), 5.15 (d, J = 5.6 Hz, 1H), 5.42 (m, 1H), 5.44 (m, 1H).
13C NMR (101 MHz, CDCl3): δ −4.4 (q), −4.1 (q), −3.9 (q),
12.3 (d), 17.4 (q), 17.7 (s), 17.9 (q), 18.1 (s), 19.3 (q), 20.7
(q), 23.0 (q), 23.1 (q), 25.9 (q), 26.0 (q), 26.7 (d), 27.1 (q),
33.9 (t), 38.3 (t), 40.9 (t), 45.0 (t), 46.0 (t), 46.9 (t), 53.1 (s),
68.4 (d), 69.0 (d), 70.3 (d), 74.1 (d), 76.1 (d), 78.5 (d), 87.3
(d), 125.7 (d), 132.7 (d), 138.9 (s), 143.4 (s), 171.1 (s), 213.9
(s). HRMS (ESI+) m/z: calcd for C48H92NaO8Si3 [M + Na]
+,
903.5992; found, 903.5993.





(−)-α-MPA (7 mg, 0.04 mmol) and EDC·HCl (10 mg, 0.05
mmol) were added to a solution of alcohol 6 (4.3 mg, 0.005
mmol) in THF (0.25 mL), then DMAP (catalytic) was added,
and the solution was stirred at 35 °C for 2 h. The solution was
poured into Et2O (5 mL) and washed with NH4Cl saturated
solution (2 × 3 mL). The organic residue was dried over
Na2SO4 and filtered, and the solvent was removed under
reduced pressure. Purification by silica gel column chromatog-
raphy with hexane/EtOAc (90:10) yielded the corresponding
ester 27 (2.2 mg, 48% br s m) and 6 (0.5 mg). 1H NMR (500
MHz, CDCl2-d2): δ 0.04 (s, 6H), 0.08 (s, 6H), 0.82 (d, J = 6.1
Hz, 3H), 0.86 (s, 9H), 0.90 (s, 9H), 1.07 (s, 21H), 1.09 (s,
3H), 1.11 (s, 3H), 1.13−1.16 (m, 1H), 1.23−1.27 (m, 1H),
1.36−1.42 (m, 1H), 1.51−1.54 (m, 1H), 1.55−1.57 (m, 1H),
1.65 (d, J = 13.9 Hz, 1H), 1.73 (d, J = 1.4 Hz, 3H), 1.79 (d, J =
1.3 Hz, 3H), 1.86−1.91 (m, 1H), 2.08−2.11 (m, 1H), 2.14 (s,
3H), 2.21−2.29 (m, 2H), 2.44 (dd, J = 13.8, 7.4 Hz, 1H), 2.62−
2.69 (m, 2H), 3.40 (s, 3H), 3.75 (ddd, J = 12.0, 7.9, 4.5 Hz,
1H), 3.88 (dd, J = 3.0, 1.2 Hz, 1H), 4.05 (dd, J = 9.9, 3.8 Hz,
1H), 4.23 (t, J = 5.8 Hz, 1H), 4.70 (s, 1H), 4.97−5.03 (m, 1H),
5.06 (dd, J = 6.0, 1.2 Hz, 1H), 5.40−5.45 (m, 1H), 5.49−5.54
(m, 1H), 5.75 (dd, J = 9.3, 3.0 Hz, 1H), 7.32−7.49 (m, 5H).
13C NMR (126 MHz, CDCl2-d2): δ −4.3 (q), −3.9 (q), −3.5
(q), 12.8 (d), 17.9 (q), 18.1 (q), 18.2 (q), 18.4 (s), 18.5 (s),
20.1 (q), 20.8 (q), 22.1 (q), 23.3 (q), 26.1 (q), 26.2 (q), 27.0
(d), 27.0 (q), 33.9 (t), 38.7 (t), 41.6 (t), 45.0 (t), 46.2 (t), 47.1
(t), 57.7 (q), 68.8 (d), 70.8 (d), 71.9 (d), 74.5 (d), 75.7 (d),
78.9 (d), 83.1 (d), 86.0 (d), 121.5 (d), 128.2 (d), 129.0 (d),
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129.2 (d), 132.9 (d), 133.5 (s), 137.1 (s), 142.1 (s), 169.9 (s),
170.8 (s), 213.0 (s). HRMS (ESI+) m/z: calcd for
C57H104NO10Si3 [M + NH4]





dioxabicyclo[11.2.1]hexadec-6-en-3-one (31). Et3N (14 μL,
0.1 mmol) and TMSOTf (11 μL, 0.06 mmol) were sequentially
added to a solution of ketone 6 (8 mg, 0.01 mmol) in CH2Cl2
(0.7 mL) at 0 °C. The reaction mixture was stirred for 3 h at rt,
diluted with CH2Cl2 (2 mL), and quenched with diluted
NH4Cl (1 mL). The organic layer was washed three times with
diluted NH4Cl, dried over MgSO4, and concentrated under
reduced pressure to obtain silylenolether 31 as a brownish oil
(10 mg, quant). The crude was pure enough to continue the
synthesis. 1H NMR (400 MHz, CDCl3): δ 0.00 (s, 3H), 0.03 (s,
3H), 0.06 (s, 6H), 0.07 (s, 9H), 0.21 (s, 9H), 0.85 (s, 9H), 0.86
(s, 9H), 0.88 (d, J = 2.9 Hz, 3H), 0.93 (s, 3H), 1.02 (s, 3H),
1.05 (s, 21H), 1.28−1.29 (m, 1H), 1.66 (s, 3H), 1.72 (s, 3H),
1.73−1.76 (m, 1H), 1.93−2.04 (m, 3H), 2.07−2.17 (m, 3H),
2.20−2.30 (m, 2H), 2.47−2.58 (m, 2H), 2.68 (dd, J = 14.6, 3.7
Hz, 1H), 3.94−3.96 (m, 2H), 3.96−4.00 (m, 2H), 4.10 (d, J =
1.6 Hz, 1H), 4.29−4.38 (m, 1H), 4.44 (dd, J = 9.1, 2.7 Hz, 1H),
4.89−4.95 (m, 1H), 5.21 (d, J = 5.7 Hz, 1H), 5.24−5.27 (m,
1H), 5.40−5.43 (m, 1H).
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■ ADDITIONAL NOTES
aFrom now onward in this publication, carbon numeration
used in the structure determination of PMs B−D will be used
for every molecular structure.
bThe structural and stereochemical characterization was
performed in the R + D department of PharmaMar.
cOther protecting groups such as TBS or PMB were tested with
worst synthetic results.
dTwo singlets at 6.18 and 6.25 ppm with 89:11 relative area
were observed in the 1H NMR.
eThe proportion of diastereomers was determined by the NMR
analysis of the purified ketol.
fSee Supporting Information.
gThe C15-(R) configuration is the opposite to the one present
in the NPs PMs C and D. See Supporting Information.
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